Pradeep Natarajan
Amgen Inc.
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Genetic Associations and Epidemiology
Strong evidence · 7 supporting papers · latest 2026
Cerebrovascular and Carotid Artery Diseases
Strong evidence · 1 supporting paper · latest 2026
Lipoproteins and Cardiovascular Health
Strong evidence · 1 supporting paper · latest 2026
Pregnancy and preeclampsia studies
Strong evidence · 1 supporting paper · latest 2026
Epigenetics and DNA Methylation
Solid evidence · 1 supporting paper · latest 2026
Cardiac Imaging and Diagnostics
Solid evidence · 1 supporting paper · latest 2026
Cardiac Health and Mental Health
Solid evidence · 2 supporting papers · latest 2026
Metabolomics and Mass Spectrometry Studies
Solid evidence · 1 supporting paper · latest 2026
Publications (15)
Genetic evidence supports the combined targeting of lipoprotein(a) and LDL cholesterol to reduce coronary artery disease risk
2026DOIPMID 42693289
Validation of a Diagnosis Code-based Definition for Clinically Relevant Carotid Stenosis
2026DOI
Hypertensive Disorders of Pregnancy and Cardiovascular-Kidney-Metabolic Syndrome
2026DOIPMID 42765319
Leukocyte DNA methylation-based signatures for atherosclerotic cardiovascular disease risk prediction in the Million Veteran Program
2026DOI
Clinician and Patient Perspectives on Cardiac Rehabilitation for Type 1 vs Type 2 Myocardial Infarction
2026DOIPMID 42771903
Comparison of performance of publicly available polygenic risk scores to predict clinically actionable coronary artery calcium scores: the BioHEART-CT cohort
2026DOIPMID 42747424
Obesity Endotypes Unmask Heterogeneous Responses to Healthy Lifestyle Behaviors
2026DOI
Plasma metabolomics and incident major adverse cardiovascular events in patients with rheumatoid arthritis
2026DOIPMID 42538831
Genetically Mediated Differences in LDL Cholesterol and Risk of Venous Thromboembolism
2026DOIPMID 42663354
Comparison of Health Status Among Patients With Type 1 Myocardial Infarction and Type 2 Myocardial Infarction: The CHAMP‐MI Study
2026DOIPMID 42786649
Machine learning–driven spleen imaging and genomics uncover a splenic connection to coronary artery disease
2026DOIPMID 42715348
Genetic Risk of Cardiovascular Disease Among People With No Standard Modifiable Risk Factors
2026DOIPMID 42663373
Clonal haematopoiesis and cardiovascular-kidney-metabolic syndrome: a cohort study
2026DOIPMID 42668426
Derivation of a blood count-based machine learning model to prioritise sequencing for high-risk clonal haematopoiesis: a retrospective cohort study
2026DOI
REPLY
2026DOIPMID 42714049
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Amgen Inc.
- Broad Institute
Source: OpenAlex · retrieved 2026-09-29
Source: ScienceWe Extractor · retrieved 2026-09-27